MedTrace Logo

Beta Blocker Effects in Traumatic Brain Injury

NCT05195996 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-03-17

No results posted yet for this study

Summary

The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma to evaluate effects of beta blocker on patients with TBI.

Conditions

  • Trauma, Brain

Interventions

DRUG

Propranolol

intravenous propranolol for case patients

DRUG

Saline

intravenous saline for placebo

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Principal Investigators

  • mostafa f mansour, MD · Menoufia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-03-31
Completion
2022-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195996 on ClinicalTrials.gov